GLUD1 and neoplasm: Glutamate can then be metabolized either to GSH by GCLC or to 2‐OG by GLUD1 and then enter the TCA cycle.[10b] To find out which metabolic pathway(s) downstream of GLS plays a primary role in regulating tumor antigen presentation, we performed in silico metabolic flux analysis using TCGA datasets.